BrightSpring Health reports Q3 diluted EPS 26c, consensus 33c

Reports Q3 revenue $3.334B, consensus $3.31B. “We are pleased with our third quarter organizational results,” said Jon Rousseau, CEO. “The performance in the quarter and ongoing progress throughout the year have been underpinned by our ability to deliver high-quality, patient-centric, and lower-cost care across the Pharmacy and Provider segments. We continue to focus on driving best practices in operations while leveraging our scale to provide quality and efficient services to complex populations in a timely, coordinated, and compassionate manner. We remain focused on executing at a high level towards BrightSpring’s goals for the remainder of 2025 and into 2026.”